RXO (RXO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
RXO, Inc. (NYSE:RXO ) Q1 2025 Earnings Conference Call May 7, 2025 8:00 AM ET Company Participants Drew Wilkerson - Chief Executive Officer Jamie Harris - Chief Financial Officer Jared Weisfeld - Chief Strategy Officer Conference Call Participants Stephanie Moore - Jefferies Chris Wetherbee - Wells Fargo David Zulong - Barclays Jeff Kauffman - Vertical Research Partners Lucas Cervera - Truist Securities Ken Hoexter - Bank of America Ravi Shankar - Morgan Stanley Brian Ossenbeck - JPMorgan Bruce Chan - Stifel Jordan Alliger - Goldman Sachs Scott Schneeberger - Oppenheimer Operator Welcome to the RXO Q1 2025 earnings conference call and webcast. My name is Joelle and I will be your conference operator for today's call.
The headline numbers for RXO (RXO) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
RXO (RXO) came out with a quarterly loss of $0.03 per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to loss of $0.03 per share a year ago.
RXO (RXO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
I downgrade RXO from buy to hold due to uncertainty in growth recovery and weak near-term outlook, expecting the stock to remain rangebound. RXO's 1Q25 guidance fell short of expectations, with adj EBITDA guidance of $20-$30 million, indicating continued volume weakness and margin pressure. Despite positive signs in contract rates and spot rates, the freight market recovery remains uncertain, posing risks to RXO's near-term performance.
RXO, Inc. (NYSE:RXO ) Q4 2024 Earnings Conference Call February 5, 2025 8:00 AM ET Company Participants Drew Wilkerson - Chief Executive Officer Jamie Harris - Chief Financial Officer Jared Weisfeld - Chief Strategy Officer Conference Call Participants Ken Hoexter - Bank of America Scott Schneeberger - Oppenheimer Joe Hafling - Jefferies Brandon Oglenski - Barclays Tom Wadewitz - UBS Chris Wetherbee - Wells Fargo Ravi Shanker - Morgan Stanley Jordan Alliger - Goldman Sachs Jason Seidl - TD Cowen Scott Group - Wolfe Research Daniel Imbro - Stephens Operator Welcome to the RXO Fourth Quarter 2024 Quarter Earnings Conference Call and Webcast. My name is Jenny and I will be your operator for today's call.
Although the revenue and EPS for RXO (RXO) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
RXO (RXO) came out with quarterly earnings of $0.06 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.06 per share a year ago.
RXO (RXO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Investors need to pay close attention to RXO stock based on the movements in the options market lately.
RXO, Inc. (NYSE:RXO ) Q3 2024 Earnings Conference Call November 7, 2024 7:00 AM ET Company Participants Drew Wilkerson - CEO Jamie Harris - CFO Jared Weisfeld - Chief Strategy Officer Conference Call Participants Ariel Rosa - Citigroup. Scott Schneeberger - Oppenheimer David Zazula - Barclays Joe Hafling - Jefferies Ken Hoexter - Bank of America Bruce Chan - Stifel Scott Group - Wolfe David Hicks - Raymond James Operator Welcome to the RXO Q3 2024 Earnings Conference Call and Webcast.